Prognostic Significance of Major Histocompatibility Complex Class II Expression in Pediatric Adrenocortical Tumors: A St. Jude and Children's Oncology Group Study

PURPOSE: Histological markers that differentiate benign and malignant pediatric adrenocortical tumors (ACTs) are lacking. Previous studies have implicated an association of major histocompatibility complex (MHC) class II expression with ACT prognosis. Here we determined the expression of MHC class I...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Cancer Res
Autori principali: Pinto, Emilia Modolo, Rodriguez-Galindo, Carlos, Choi, John Kim, Pounds, Stanley, Liu, Zhifa, Neale, Geoff, Finkelstein, David, Hicks, John, Pappo, Alberto S., Figueiredo, Bonald, Ribeiro, Raul C., Zambetti, Gerard P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5159323/
https://ncbi.nlm.nih.gov/pubmed/27307598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-2738
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi